1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional)" is currently closed and not accepting applications.
High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional) is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This program supports high impact ideas that may lay the foundation for new fields of investigation within the mission of NIDDK, with an emphasis on interdisciplinary approaches to generate research resources or foster discovery-based/hypothesis-generating science to accelerate scientific progress in understanding, treatment, and prevention of diseases within NIDDK's mission.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
RC2: High Impact, Interdisciplinary Science in NIDDK Research Areas (Clinical Trial Optional) - NIDDK RC2: High Impact, Interdisciplinary Science in NIDDK Research Areas (Clinical Trial Optional) Most recent NIDDK funding announcement: PAR-25-277 There are two ways that researchers can address scientific challenges using an interdisciplinary team approach.
These include: Multiple-Principal Investigator Initiated Research Project (Multi-PI R01)- PA 20-185 (clinical trial not allowed) and PA-20-183 (clinical trial required) RC2 mechanism for High Impact, Interdisciplinary Science - PAR-25-277 A Multi-PI R01 has a focused, more narrow thrust that addresses an overall hypothesis. There are typically two or more PIs working collaboratively to address two or more related Specific Aims.
Supporting preliminary data is essential as a foundation for the studies being proposed. In contrast, the RC2 at NIDDK is a single project using an interdisciplinary team approach that generates a research resource for the community, is discovery based and/or hypothesis generating. NIDDK looks for these RC2 projects to accelerate critical breakthroughs in biomedical research that is relevant to the mission of NIDDK.
These will be high impact ideas that may lay the foundation for new fields of research and be groundbreaking, high impact, cross-cutting, hypothesis-generating research.
NIDDK envisions that RC2 projects will: take novel approaches to address specific knowledge gaps in the field of interest to NIDDK take advantage of scientific opportunities develop new technologies; and/or generate data or research methods that are useful for the scientific community An important aspect of the RC2 projects is that the team will share data and/or resources with the scientific community-and include a sustainability plan for the sharing of the data/resources beyond the period of RC2 funding.
While prior collaboration among the team of investigators is not required, the team must provide a plan for working together that will enhance integration and collaboration.
This separate attachment to the RC2 application should address: how the team will facilitate interactions how the RC2 will enhance integration and collaboration the overall organization of the team including lines of communication More information on and a comparison among these collaborative grant mechanisms supported by NIDDK can be found in the collaborative grants comparison table.
Applicants are strongly encouraged to discuss proposed studies with NIDDK staff and generate a Pre-approval letter at least 3 months, and preferably 6 months before submission. The pre-approval process is key as program staff will consider the following: Importance of the complex problem or resource to the NIDDK mission Will the proposed research significantly advance the mission of NIDDK?
How does the proposed research relate to currently funded research in NIDDK and by the investigative team? Is the proposed work appropriate for the RC2 activity code?
If your proposed project does not fit the RC2 mechanism, staff will suggest other options for your proposed research RC2 Frequently Asked Questions Division of Digestive Diseases and Nutrition Division of Kidney, Urologic, and Hematologic Diseases Division of Diabetes, Endocrinology, and Metabolic Diseases Last Reviewed December 2024
According to the current listing, eligibility includes: Eligible applicants include various government entities, businesses (for-profit and small businesses), non-profit organizations, and educational institutions (public/state and private higher education). Also includes Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs). Confirm the full requirements in the official notice before applying.
The published deadline was May 13, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional) is funded by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Alaska. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program